Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
Review a list of all the innovative programs and initiatives that NCATS supports.
NCATS released a funding opportunity to explore a potential new use of an existing drug or biologic through its Bench-to-Clinic Repurposing initiative.
NCATS showcases web-based platform of patient-focused rare diseases research resources at NIH event in September.
Read about the NCATS Toolkit for Patient-Focused Therapy Development, a TRND-FDA partnership to fund rare diseases studies, NIH efforts to increase diversity in research, and more.
NCATS’ TRND program is supporting two natural history studies on how specific rare diseases progress over time.
CTSA Program-supported scientists work to develop novel technique to test drugs against the most common form of brain cancer.
Michael G. Kurilla will serve as director of the Division of Clinical Innovation.
NCATS announced 13 awards to develop 3-D tissue chip research platforms
Christopher P. Austin, M.D.
Funded activities under the NCATS Clinical and Translational Science Awards (CTSA) Program (PDF - 89KB)
Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …